Sidoti Downgrades Haemonetics (HAE) to Neutral
- Wall Street falls as post-election winners lag
- The FTC Confirms Antitrust Charges Against Qualcomm (QCOM) for Monopolizing Semiconductor Device Used in Cell Phones
- United Airlines (UAL) Tops Q4 EPS by 5c
- Obama commutes sentence of intelligence analyst Chelsea Manning
- Big 5 Sporting Goods (BGFV) Q4 Comps Rise 3.1%; Guides Q4 Above the Street
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Sidoti downgraded Haemonetics (NYSE: HAE) from Buy to Neutral with a price target of $39 (unchanged).
Shares of Haemonetics closed at $36.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: JPMorgan Downgrades OneMain (OMF) to Neutral
- Morgan Stanley Downgrades The Container Store (TCS) to Underweight
- Macquarie Downgrades Everest Re Group (RE) to Underperform
Create E-mail Alert Related CategoriesDowngrades
Related EntitiesSidoti & Company
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!